Navigation Links
BD Announces CE Marking of a New Molecular Test to Diagnose Patients with Clostridium difficile Infections
Date:7/6/2008

BD GeneOhm(TM) Cdiff Assay Submitted for FDA Clearance

SAN DIEGO, July 7 /PRNewswire-FirstCall/ -- BD Diagnostics, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), announced today the CE marking of the BD GeneOhm(TM) Cdiff molecular assay for the rapid diagnosis of patients with Clostridium difficile infection (CDI). It is the first CDI diagnostic test that offers sensitivity, simplicity and speed in one test procedure. BD has also submitted this assay to the U.S. Food and Drug Administration for clearance.

CE marked under the European In Vitro Diagnostics Directive for the identification of toxigenic Clostridium difficile directly from stool specimens, the BD GeneOhm Cdiff assay targets the toxin B gene, found in toxigenic Clostriduim difficile strains. It is the only CDI diagnostic test that combines high assay sensitivity with a rapid turnaround time of less than two hours, facilitating earlier appropriate treatment of patients suffering from CDI and earlier implementation of infection control interventions to prevent transmission of Clostridium difficile to other patients. Until now, rapid diagnosis of CDI has been difficult since traditional methods consist of immunoassays, which lack sufficient sensitivity, and traditional "gold standard" tissue culture cytotoxicity methods, which are difficult to perform and require several days to yield results.

"The BD GeneOhm Cdiff assay provides a simple and rapid stool test with excellent sensitivity and specificity that allows same-day identification of toxigenic Clostridium difficile," said Thomas Davis, M.D., Ph.D., Professor, Pathology and Laboratory Medicine, Clarian Pathology Laboratory. "This test should improve patient care because it effectively
'/>"/>

SOURCE BD-Becton Dickinson
Copyright©2008 PR Newswire.
All rights reserved

3

GOOD

Page: 1 2 3

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
7. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
8. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
9. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
10. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... Utah , May 22, 2013  Aribex, Inc., ... X-ray system, today introduced a new color option, black ... the U.S. dental and veterinary markets. The popular white ... last month will continue to be available and both ... dealers. (Photo: http://photos.prnewswire.com/prnh/20130522/CL19573 ) ...
(Date:5/22/2013)... Colo. , May 22, 2013  Heska Corporation (NASDAQ: ... diagnostic and specialty products, announced today that the Company will ... Wednesday, May 29, 2013 at the Le Parker Meridian hotel, ... York City . The presentation is scheduled to begin ... About Heska Heska Corporation (NASDAQ: ...
(Date:5/22/2013)... 2013 Advanced Prenatal Therapeutics (APT), a privately ... help alleviate the high blood pressure and other symptoms ... to be the first medical device specifically designed to ... death. Every year, preeclampsia affects approximately 300,000 ... . It is characterized by high blood pressure and ...
Breaking Medicine Technology:Aribex Unveils New Color of NOMAD Pro 2 2Advanced Prenatal Therapeutics - Using Targeted Apheresis to Treat Preeclampsia 2
... Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH ), ... associated with inflammation, today announced it will hold a ... investigation and remediation plans relating to vial problems in ... 14, 2010Time: , 5:00 pm Eastern TimeDomestic Dial-in: , ...
... 9, 2010 HeartWare International, Inc. (Nasdaq: ... offer, subject to market and other conditions, $100 million ... "notes") pursuant to an effective shelf registration statement filed ... also intends to grant the underwriters an option to ...
Cached Medicine Technology:Anthera Announces Update Call Regarding Vial Problems 2HeartWare International, Inc. Announces Concurrent Public Offerings of Convertible Senior Notes and Common Stock 2HeartWare International, Inc. Announces Concurrent Public Offerings of Convertible Senior Notes and Common Stock 3
(Date:5/22/2013)... 2013 Textile Exchange, a non-profit ... textile industry, today released the 2011-12 Farm & ... cotton production dropped 8% from last year. This ... 37% drop in 2010-11. Half of the organic ... report, Textile Exchange’s seventh, provides unique data, trends ...
(Date:5/22/2013)... 22, 2013 On May 16, 2012, ... on average, a funeral concierge can help families negotiate lower ... Funeral Financials announces their top 3 reasons ... income in the U.S. having dropped 7.3 percent from ... the average funeral costs 12.6% of an average U.S. households ...
(Date:5/22/2013)... The Yoga of Lady Niguma was created by a ... This is the oldest yoga found in written form (in ... the partner of renowned Indian master and yogi Naropa, and the ... a female yoga master. , Lady Niguma taught the practice ... through a long lineage to the second Dalai Lama, Gendun Gyatso. ...
(Date:5/22/2013)... CA (PRWEB) May 22, 2013 Dr. Andrew ... to painful scalpel surgery with the Laser Assisted New Attachment ... is raising awareness about the connections between gum disease and ... concerns in the United States today, and is linked to ... of bacteria found in the infected gum pockets. , ...
(Date:5/22/2013)... MD (PRWEB) May 22, 2013 On a ... Lisa, spent a few hours watching “The Bourne Legacy” at ... While this may seem like a typical activity to many ... This little stretch of respite from their everyday reality has ... Seals Serving DC | MD | VA. , Life changed ...
Breaking Medicine News(10 mins):Health News:Organic Cotton Sector Shows Signs of Stabilizing, Demonstrating Strength and Commitment of Producer Groups, According to 2011-12 Textile Exchange Farm & Fiber Report 2Health News:Organic Cotton Sector Shows Signs of Stabilizing, Demonstrating Strength and Commitment of Producer Groups, According to 2011-12 Textile Exchange Farm & Fiber Report 3Health News:Organic Cotton Sector Shows Signs of Stabilizing, Demonstrating Strength and Commitment of Producer Groups, According to 2011-12 Textile Exchange Farm & Fiber Report 4Health News:Funeral Financials Announces Their Top 3 Reasons to Hire a Funeral Concierge 2Health News:Funeral Financials Announces Their Top 3 Reasons to Hire a Funeral Concierge 3Health News:Popular Yoga DVD, Lady Niguma Yoga Released for Sale Online 2Health News:Popular Yoga DVD, Lady Niguma Yoga Released for Sale Online 3Health News:For Stroke Awareness Month, Dr. Andrew Satlin is Raising Awareness of the Connections Between Gum Disease and Stroke and Offers Encino, CA Laser Gum Surgery for Treatment 2Health News:Military Family Finds Respite with Easter Seals 2Health News:Military Family Finds Respite with Easter Seals 3
... as HIV and Hepatitis C decades back, will now get ... inquiry is soon to be launched into the contracting of ... transfusions, in what is acknowledged as the biggest treatment blunder ... , The incident took place in the late 70s ...
... study has revealed for the first time that rice bran ... research was conducted by biomedical scientists at the Department of ... has not been tested on humans, but research in the ... has been published in the British Journal of Cancer. ...
... of the “triple negative” type are destructive and lethal, and ... a novel// study Published in the May 1, 2007 issue ... tumors occur commonly among women who are African American and ... lower socioeconomic status (SES). The study also showed that triple ...
... cells to regenerate healthy human liver tissue in a ... the liver, some patients are unable to undergo surgery, ... liver to support the body. ,Researchers at ... cells to help quickly regenerate healthy liver tissue, enabling ...
... technology has found that the most potent cholesterol-lowering ... in the blood vessels that can lead to ... thickened carotid arteries compared to a placebo,” said ... of endocrinology at Wake Forest University School of ...
... southern Indian state of Karnataka is examining a proposal to ... test before marriage. ,State Health Minister R. ... government had written a letter to the federal government suggesting ... were several instances in which unsuspecting women had married HIV+ ...
Cached Medicine News:Health News:Inquiry into Past NHS Treatment Disaster 2Health News:'Triple Negative' Breast Cancers Seem to Affect the Young, Minority 2Health News:Stem Cells to Treat Liver Cancer 2Health News:Cholesterol-lowering Drug Effective at Halting Early Atherosclerosis 2
ScanGel® Centrifuge...
BIOVUE cassettes may be used manually, with a workstation consisting of a centrifuge, incubator, precision pipettes and work rack....
... The ID-Micro Typing System™ ... for a broad range of ... include antibody screening and identification, ... phenotyping, compatibility testing, reverse serum ...
... accommodates up to 12 large slab gels, ... the PROTEAN IEF system, for high-throughput 2-D ... Plus Dodeca cell's cooling and recirculating capabilities, ... high-resolution results. The handcasting system includes the ...
Medicine Products: